BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.

News & Events

BD to Present at Investor Healthcare Conferences

BD Initiates New Industry Alliance To Combat Rising Opioid Crisis

BD 2017 First Fiscal Quarter Financial Presentation

BD Announces Results for 2017 First Fiscal Quarter

New BD Institute For Medication Management Excellence Aims To Improve Patient Safety And Outcomes Through Collaboration

BD Board Declares Dividend

BD Announces Webcast of Annual Meeting of Shareholders

BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

BD to Present at the 35th Annual J. P. Morgan Healthcare Conference

2016 Analyst Day Presentations

BD Announces 2016 Analyst Day and Webcast

BD Fourth Quarter and Full-Year Results Fiscal Year 2016 Financial Presentation

BD Announces Results for 2016 Fourth Fiscal Quarter and Full Year

BD and Apax Partners Announce Closing of Joint Venture to Launch Global Respiratory Business

BD Unveils Next Generation Wireless Point-of-Care Diagnostic Device

BD Cited as Infusion Pump EMR Integration Leader in Klas Report

BD Receives FDA Clearance for New Syringe Designed for the Administration of Humulin® R U-500 Insulin

BD Names R. Andrew Eckert To Board Of Directors

BD Hits Century Mark With Infusion Pump Interoperability

BD and Check-Points Announce Development and Global Distribution Agreement for BD MAX™ Assays that Detect Carbapenem—resistant Organisms

BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody™ System

BD Expands Reproductive and Sexually Transmitted Infections Portfolio with CE Mark for the BD MAX™ Vaginal Panel

BD Introduces New Low-Temperature Sterilization Containers

BD, Apax Partners to Form Joint Venture for Respiratory Solutions

Alaris™ System Named 2015 Best In KLAS for Smart Pumps


carefusion joins bd pdf
Annual Report
AdvaMed Life Changing Innovation
Sustainability Report 2014